Back to News and Publications

Selected 2015 Life Sciences Transactions

  • 5.6.2015
Recognized both globally and nationally as a leading life sciences practice, WilmerHale has four decades of experience representing biotechnology, pharmaceutical and medical device companies at all stages of growth, as well as venture capitalists and investment banks.

2015-WH-LifeSciences-Deals

Not sure where to start?

Let our Knowledge Navigator direct you to content specific to where you are on your journey.

Get Started!
Featured
blog-launch-550x370

This blog post explores certain specific terms in term sheets that will create legally binding obligations.

Schall launch feature

Partner Gary Schall shares some practical advice about term sheets: Don’t attempt any transaction without one.

Rss Feed
12.20.2024
Players rebuke clumsy ad strategies, even in popular games | Mobile Premier League 
12.20.2024
Arm lawsuit against Qualcomm ends in mistrial and favorable ruling for Qualcomm 
12.20.2024
Players invested 8.34B hours into Blizzard titles in 2024, says studio 
Build
Document Generator  
Startup Dictionary  
Research
12.9.2024
Corporate Transparency Act: FinCEN Provides Guidance in Response to Federal District Court Preliminarily Enjoining Enforcement of the CTA and its Reporting Rule
4.2.2024
Corporate Transparency Act: What is a Reporting Company?
4.1.2024
Corporate Transparency Act: Entities Formed in Early January Must Comply with the CTA as Early as Today